Contrato de Suministro de Medicamentos: Insulinas Inyectables para Hospital de Curico
1. Que, el Hospital San Juan de Dios de Curicó requiere adquirir Insulinas Inyectables, en forma permanente con el objetivo de poder cumplir debidamente con la demanda asistencial y otorgar atención a los usuarios del establecimiento de forma oportuna.
2 oferente(s) participaron en esta licitación. El detalle de quién compitió y con qué oferta está en el registro oficial de Mercado Público.
Ver oferentes en Mercado Público →| Código | Fecha | Proveedor | Monto |
|---|---|---|---|
| 4463-237-SE21 | 11-02-2021 | Novo Nordisk Farmaceutica Limitada | $3.153.500 |
| 4463-236-SE21 | 11-02-2021 | Aventis Pharma Holding Gmbh | $6.747.300 |
| 4463-193-SE21 | 09-02-2021 | Novo Nordisk Farmaceutica Limitada | $1.576.750 |
| 4463-167-SE21 | 01-02-2021 | Aventis Pharma Holding Gmbh | $6.747.300 |
| 4463-51-SE21 | 13-01-2021 | Novo Nordisk Farmaceutica Limitada | $1.261.400 |
| 4463-50-SE21 | 13-01-2021 | Aventis Pharma Holding Gmbh | $6.747.300 |
| 4463-2-SE21 | 05-01-2021 | Aventis Pharma Holding Gmbh | $6.747.300 |
| 4463-2123-SE20 | 18-12-2020 | Novo Nordisk Farmaceutica Limitada | $1.261.400 |
| 4463-2059-SE20 | 11-12-2020 | Aventis Pharma Holding Gmbh | $5.847.660 |
| 4463-2055-SE20 | 10-12-2020 | Aventis Pharma Holding Gmbh | $1.349.460 |
| 4463-1995-SE20 | 25-11-2020 | Aventis Pharma Holding Gmbh | $1.349.460 |
| 4463-1930-SE20 | 30-10-2020 | Aventis Pharma Holding Gmbh | $2.249.100 |
| 4463-1773-SE20 | 01-10-2020 | Aventis Pharma Holding Gmbh | $13.494.600 |
| 4463-1612-SE20 | 02-09-2020 | Aventis Pharma Holding Gmbh | $13.494.600 |
| 4463-1416-SE20 | 29-07-2020 | Aventis Pharma Holding Gmbh | $13.494.600 |
| 4463-1262-SE20 | 02-07-2020 | Aventis Pharma Holding Gmbh | $8.096.760 |
| 4463-1244-SE20 | 23-06-2020 | Novo Nordisk Farmaceutica Limitada | $1.261.400 |
| 4463-1140-SE20 | 02-06-2020 | Novo Nordisk Farmaceutica Limitada | $3.611.650 |
| 4463-1135-SE20 | 01-06-2020 | Aventis Pharma Holding Gmbh | $15.743.700 |
| 4463-995-SE20 | 12-05-2020 | Novo Nordisk Farmaceutica Limitada | $1.576.750 |
| 4463-924-SE20 | 05-05-2020 | Novo Nordisk Farmaceutica Limitada | $2.665.600 |
| 4463-919-SE20 | 30-04-2020 | Aventis Pharma Holding Gmbh | $8.996.400 |
| 4463-687-SE20 | 30-03-2020 | Novo Nordisk Farmaceutica Limitada | $1.332.800 |
| 4463-623-SE20 | 25-03-2020 | Aventis Pharma Holding Gmbh | $8.996.400 |
| 4463-478-SE20 | 18-03-2020 | Novo Nordisk Farmaceutica Limitada | $6.836.550 |
| 4463-432-SE20 | 04-03-2020 | Aventis Pharma Holding Gmbh | $13.494.600 |
| 4463-197-SE20 | 31-01-2020 | Aventis Pharma Holding Gmbh | $8.996.400 |
| 4463-198-SE20 | 31-01-2020 | Novo Nordisk Farmaceutica Limitada | $2.332.400 |
| 4463-2907-SE19 | 31-12-2019 | Novo Nordisk Farmaceutica Limitada | $3.927.000 |
| 4463-2898-SE19 | 20-12-2019 | Aventis Pharma Holding Gmbh | $13.494.600 |
| 4463-2576-SE19 | 15-12-2019 | Aventis Pharma Holding Gmbh | $15.743.700 |
| 4463-2577-SE19 | 15-12-2019 | Novo Nordisk Farmaceutica Limitada | $2.612.050 |
| 4463-2394-SE19 | 14-11-2019 | Aventis Pharma Holding Gmbh | $11.245.500 |
| 4463-2237-SE19 | 28-10-2019 | Novo Nordisk Farmaceutica Limitada | $6.307.000 |
| 4463-2152-SE19 | 17-10-2019 | Novo Nordisk Farmaceutica Limitada | $1.576.750 |
| 4463-2119-SE19 | 04-10-2019 | Aventis Pharma Holding Gmbh | $11.245.500 |
| 4463-1988-SE19 | 04-09-2019 | Novo Nordisk Farmaceutica Limitada | $946.050 |
| 4463-1976-SE19 | 04-09-2019 | Aventis Pharma Holding Gmbh | $11.245.500 |
| 4463-1838-SE19 | 19-08-2019 | Aventis Pharma Holding Gmbh | $13.494.600 |
| 4463-1840-SE19 | 19-08-2019 | Novo Nordisk Farmaceutica Limitada | $1.261.400 |
Fuente original:ficha mercadopublico.cl
